SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-267023
Filing Date
2019-10-15
Accepted
2019-10-15 06:30:36
Documents
15
Period of Report
2019-10-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d810759d8k.htm   iXBRL 8-K 62900
2 EX-99.1 d810759dex991.htm EX-99.1 40389
7 GRAPHIC g810759g55k91.jpg GRAPHIC 40049
  Complete submission text file 0001193125-19-267023.txt   364493

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA agn-20191014.xsd EX-101.SCH 5355
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agn-20191014_def.xml EX-101.DEF 15642
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE agn-20191014_lab.xml EX-101.LAB 26593
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agn-20191014_pre.xml EX-101.PRE 16935
12 EXTRACTED XBRL INSTANCE DOCUMENT d810759d8k_htm.xml XML 10834
Mailing Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400
Business Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400 (216) 523-5000
Allergan plc (Filer) CIK: 0001578845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36867 | Film No.: 191148981
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences